Research helps unlock gene secrets of autosomal dominant nocturnal frontal lobe epilepsy

October 22, 2012
Research helps unlock gene secrets of autosomal dominant nocturnal frontal lobe epilepsy

In a national research partnership, Dr Sarah Heron from the University of South Australia's Sansom Research Institute, epilepsy research group, has been working to map the genes responsible for a rare form of epilepsy - autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE).

Dr Heron and her team's latest research to identify a new gene for this form of epilepsy has been published in this month.  

She says while ADNFLE affects a relatively rare group of people, the symptoms and impact of the condition can be devastating.

"ADNFLE usually develops in childhood and characterised by clusters of seizures during sleep," Dr Heron says.

 "It can have an association with cognitive deficits and or psychiatric comorbidity.

 "Our research has identified that mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy and associated intellectual and or psychiatric disability."

UniSA's epilepsy research group is led by Associate Professor Leanne Dibbens.  The gener-discovery research has been undertaken with support from the National Health and Medical Research Council of Australia and in collaboration with researchers at The University of Melbourne's Clinical College's Epilepsy Research Centre.

Dr Heron says the identification of the gene has important implications for and also for understanding more about the full spectrum of epilepsy disorders.

Related Stories

Recommended for you

Blocking a gene reduces fat

July 29, 2015

By blocking the expression of a certain gene in patients, University of Montreal researchers have contributed to the demonstration of great decreases in the concentration of triglycerides in their blood, even in various severe ...

Study identifies 'major player' in skin cancer genes

July 27, 2015

A multidisciplinary team at Yale, led by Yale Cancer Center members, has defined a subgroup of genetic mutations that are present in a significant number of melanoma skin cancer cases. Their findings shed light on an important ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.